Cantor Fitzgerald Reiterates Overweight on Teladoc Health, Maintains $10 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on Teladoc Health (NYSE:TDOC) and maintained a $10 price target.
August 20, 2024 | 3:23 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald has reiterated an Overweight rating on Teladoc Health, maintaining a $10 price target, indicating confidence in the company's potential.
The reiteration of an Overweight rating and maintenance of a $10 price target by a reputable analyst suggests a positive outlook for Teladoc Health. This could lead to increased investor confidence and potential upward movement in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100